|
1
|
Wang J, Wei H, Zhao B, Li M, Lv W, Lv L,
Song B and Lv S: The reverse effect of X-ray irradiation on
acquired gefitinib resistance in non-small cell lung cancer cell
line NCI-H1975 in vitro. J Mol Histol. 45:641–652. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu SV and Giaccone G: Lung cancer in
2013: Refining standard practice and admitting uncertainty. Nat Rev
Clin Oncol. 11:69–70. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Osada H and Takahashi T: Genetic
alterations of multiple tumor suppressors and oncogenes in the
carcinogenesis and progression of lung cancer. Oncogene.
21:7421–7434. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ohtsuka T, Sakamoto M, Guillemot F and
Kageyama R: Roles of the basic helix-loop-helix genes Hes1 and Hes5
in expansion of neural stem cells of the developing brain. J Biol
Chem. 276:30467–30474. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ohtsuka T, Ishibashi M, Gradwohl G,
Nakanishi S, Guillemot F and Kageyama R: Hes1 and Hes5 as notch
effectors in mammalian neuronal differentiation. EMBO J.
18:2196–2207. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hatakeyama J and Kageyama R: Notch1
expression is spatiotemporally correlated with neurogenesis and
negatively regulated by Notch1-independent Hes genes in the
developing nervous system. Cereb Cortex. 16:(Suppl 1). i132–i137.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Axelson H: The Notch signaling cascade in
neuroblastoma: Role of the basic helix-loop-helix proteins HASH-1
and HES-1. Cancer Lett. 204:171–178. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kunnimalaiyaan M, Yan S, Wong F, Zhang YW
and Chen H: Hairy enhancer of Split-1 (HES-1), a Notch1 effector,
inhibits the growth of carcinoid tumor cells. Surgery.
138:1137–1142; discussion 1142. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ström A, Arai N, Leers J and Gustafsson
JA: The hairy and enhancer of Split homologue-1 (HES-1) mediates
the proliferative effect of 17beta-estradiol on breast cancer cell
lines. Oncogene. 19:5951–5953. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yu HC, Qin HY, He F, Wang L, Fu W, Liu D,
Guo FC, Liang L, Dou KF and Han H: Canonical notch pathway protects
hepatocytes from ischemia/reperfusion injury in mice by repressing
reactive oxygen species production through JAK2/STAT3 signaling.
Hepatology. 54:979–988. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Haura EB, Zheng Z, Song L, Cantor A and
Bepler G: Activated epidermal growth factor receptor-Stat-3
signaling promotes tumor survival in vivo in non-small cell lung
cancer. Clin Cancer Res. 11:8288–8294. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Malanga D, De Marco C, Guerriero I,
Colelli F, Rinaldo N, Scrima M, Mirante T, De Vitis C, Zoppoli P,
Ceccarelli M, et al: The Akt1/IL-6/STAT3 pathway regulates growth
of lung tumor initiating cells. Oncotarget. 6:42667–42686.
2015.PubMed/NCBI
|
|
14
|
Xue Q, Zhou Y, Wan C, Lv L, Chen B, Cao X,
Ju G, Huang Y, Ni R and Mao G: Epithelial membrane protein 3 is
frequently shown as promoter methylation and functions as a tumor
suppressor gene in non-small cell lung cancer. Exp Mol Pathol.
95:313–318. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ji L, Ni T, Shen Y, Xue Q, Liu Y, Chen B,
Cui X, Lv L, Yu X, Cui Y, et al: Transformer 2β (Tra2β/SFRS10)
positively regulates the progression of NSCLC via promoting cell
proliferation. J Mol Histol. 45:573–582. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ni T, Mao G, Xue Q, Liu Y, Chen B, Cui X,
Lv L, Jia L, Wang Y and Ji L: Upregulated expression of ILF2 in
non-small cell lung cancer is associated with tumor cell
proliferation and poor prognosis. J Mol Histol. 46:325–335. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen J, Gu J, Feng J, Liu Y, Xue Q, Ni T,
Wang Z, Jia L, Mao G and Ji L: TAB3 overexpression promotes cell
proliferation in non-small cell lung cancer and mediates
chemoresistance to CDDP in A549 cells via the NF-kappaB pathway.
Tumour Biol. 37:3851–3861. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xue Q, Lv L, Wan C, Chen B, Li M, Ni T,
Liu Y, Liu Y, Cong X, Zhou Y, et al: Expression and clinical role
of small glutamine-rich tetratricopeptide repeat (TPR)-containing
protein alpha (SGTA) as a novel cell cycle protein in NSCLC. J
Cancer Res Clin Oncol. 139:1539–1549. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Weng MT, Tsao PN, Lin HL, Tung CC, Change
MC, Chang YT, Wong JM and Wei SC: Hes1 increases the invasion
ability of colorectal cancer cells via the STAT3-MMP14 pathway.
PLoS One. 10:e01443222015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu J, Lu WG, Ye F, Cheng XD, Hong D, Hu
Y, Chen HZ and Xie X: Hes1/Hes5 gene inhibits differentiation via
down-regulating Hash1 and promotes proliferation in cervical
carcinoma cells. Int J Gynecol Cancer. 20:1109–1116. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gao F, Huang W, Zhang Y, Tang S, Zheng L,
Ma F, Wang Y, Tang H and Li X: Hes1 promotes cell proliferation and
migration by activating Bmi-1 and PTEN/Akt/GSK3β pathway in human
colon cancer. Oncotarget. 6:38667–38680. 2015.PubMed/NCBI
|
|
22
|
Ito T, Udaka N, Yazawa T, Okudela K,
Hayashi H, Sudo T, Guillemot F, Kageyama R and Kitamura H: Basic
helix-loop-helix transcription factors regulate the neuroendocrine
differentiation of fetal mouse pulmonary epithelium. Development.
127:3913–3921. 2000.PubMed/NCBI
|
|
23
|
Kitamoto M, Nakanishi T, Kira S, Kawaguchi
M, Nakashio R, Suemori S, Kajiyama G, Asahara T and Dohi K: The
assessment of proliferating cell nuclear antigen
immunohistochemical staining in small hepatocellular carcinoma and
its relationship to histologic characteristics and prognosis.
Cancer. 72:1859–1865. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Del Gobbo A, Pellegrinelli A, Gaudioso G,
Castellani M, Marino F Zito, Franco R, Palleschi A, Nosotti M,
Bosari S, Vaira V, et al: Analysis of NSCLC tumour heterogeneity,
proliferative and 18F-FDG PET indices reveals Ki-67 prognostic role
in adenocarcinomas. Histopathology. 68:746–751. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kamakura S, Oishi K, Yoshimatsu T,
Nakafuku M, Masuyama N and Gotoh Y: Hes binding to STAT3 mediates
crosstalk between Notch and JAK-STAT signalling. Nat Cell Biol.
6:547–554. 2004. View
Article : Google Scholar : PubMed/NCBI
|
